Skip to content

Effect of intraoperative esketamine infusion on postoperative delirium in elderly patients with hip fracture

Effect of intraoperative esketamine infusion on postoperative delirium in elderly patients with hip fracture - a double-blind randomized placebo-controlled study

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081681
Enrollment
Unknown
Registered
2024-03-08
Start date
2024-03-08
Completion date
Unknown
Last updated
2024-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative delirium

Interventions

Esketamine group:Esketamine was continuously infused with 0.3 mg/kg/h intraoperatively
Control group:Normal saline was infused at the same rate intraoperatively

Sponsors

Chengdu integrated TCM &Western Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 100 Years

Inclusion criteria

Inclusion criteria: (1)Patients undergoing elective hip fracture surgery(including femoral neck, femoral head, intertrochanteric, or subtrochanteric fracture), (2) age = 65 years old, (3) a body mass index of 18 to 30 kg/m^2, (4) an American Society of Anesthesiologists grade I-III, and(5) Informed consent for anesthesia was signed voluntarily.

Exclusion criteria

Exclusion criteria: Multiple injuries, multiple fractures and fracture types other than the inclusion criteria (pathological, pelvic and femoral fractures);Combined neurological diseases (such as parkinsonism) or psychiatric diseases (such as schizophrenia) or preoperative mini-mental State Examination (MMSE) score < 23;Unable to complete the neuropsychological assessment and score determination for any reason (severe visual, auditory, or language communication impairment); intolerance or allergy to esketamine; history of liver and kidney dysfunction; a history of alcohol, psychotropic drugs abuse; severe intraoperative or postoperative complications

Design outcomes

Primary

MeasureTime frame
incidence of delirium within the first 3 postoperative days;

Secondary

MeasureTime frame
subtypes of delirium;duration of delirium;30-day all-cause mortality;pain score within the first 3 days after surgery;length of hospitalization;

Countries

China

Contacts

Public ContactShao Changhui

Chengdu integrated TCM &Western Medicine Hospital

814660661@qq.com+86 187 8204 5664

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026